Lokesh Agrawal directs and leads Biospecimen Research Network (BRN)-PI-led projects on human biospecimen integrity and biomarker development by studying preanalytical variables using proteomics and molecular approaches. Dr. Agrawal came to NCI from MedImmune Inc. Prior to MedImmune he worked at Rapid Pharmaceuticals, Inc. He earned his Ph.D. from All India Institute of Medical Sciences, India and did his M.S., and B.S. at different institutions in India.
JTEHM, Articles, Published ArticlesThe National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring and Treatment in Low- and Middle-Income Countries
Paul C. Pearlman, Rao Divi, Michael Gwede, Pushpa Tandon, Brian S. Sorg, Miguel R. Ossandon, Lokesh Agrawal, Vinay Pai, Houston Baker, Tiffani Bailey Lash
This Article is Featured in the Special Issue NIH-IEEE POCT 2015 Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise,... Read more
Posted on 12 SEP 2016